USMJ Annual Revenue Increases 44% to $742,000 With Gross Margin Over 50%
November 03 2017 - 11:40AM
InvestorsHub NewsWire
Dallas, TX – November 03, 2017 -- InvestorsHub
NewsWire -- North American Cannabis Holdings, Inc. (USMJ)
has released its annual financial report for the fiscal year end
2017. The company reported year to year revenue growth of 44%
with revenue increasing from $515,000 in 2016 to $742,000.
The company reported a gross margin of $408,000 reflecting a gross
margin rate of over 50%. The company plans to continue
investing in high margin top line growth and anticipates ongoing
operating losses as increased expenses precede increased revenue
growth. The USMJ 2017 annual report has been published on
OTC Markets. Management
plans to publish a shareholder update next week on the company’s
website with more insight into the annual report and future plans
for growth.
As of the filing of this press release, OTC
Markets has not yet updated USMJ to “current” status. USMJ
management anticipates the “current” update
imminently.
Learn more about USMJ, its parent company, ACI,
and ACI’s other holdings to include PURA by
visiting: http://www.aciconglomerated.com/
Disclaimer/Safe Harbor: This news release
contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
ACI, USMJ and PURA contact info:
Steven Rash
info@aciconglomerated.com
+1-800-861-1350
https://www.aciconglomerated.com/contact/
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024